Duratia: Clinically Proven Erectile Dysfunction Relief
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.44 | $43.18 (0%) | 🛒 Add to cart |
| 60 | $1.29 | $86.35 $77.32 (10%) | 🛒 Add to cart |
| 90 | $1.14 | $129.53 $102.42 (21%) | 🛒 Add to cart |
| 120 | $1.05 | $172.71 $125.52 (27%) | 🛒 Add to cart |
| 180 | $0.95 | $259.06 $171.71 (34%) | 🛒 Add to cart |
| 270 | $0.86 | $388.60 $230.95 (41%) | 🛒 Add to cart |
| 360 | $0.70
Best per pill | $518.13 $253.04 (51%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.32 | $43.18 (0%) | 🛒 Add to cart |
| 20 | $3.82 | $86.35 $76.31 (12%) | 🛒 Add to cart |
| 30 | $3.65 | $129.53 $109.45 (16%) | 🛒 Add to cart |
| 60 | $1.67 | $259.06 $100.41 (61%) | 🛒 Add to cart |
| 90 | $1.43 | $388.60 $128.53 (67%) | 🛒 Add to cart |
| 120 | $1.29 | $518.13 $154.64 (70%) | 🛒 Add to cart |
| 180 | $1.14 | $777.19 $205.85 (74%) | 🛒 Add to cart |
| 270 | $1.05 | $1165.79 $282.16 (76%) | 🛒 Add to cart |
| 360 | $0.99
Best per pill | $1554.38 $357.47 (77%) | 🛒 Add to cart |
| Product dosage: 90mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.86 | $57.24 (0%) | 🛒 Add to cart |
| 30 | $2.14 | $85.85 $64.26 (25%) | 🛒 Add to cart |
| 60 | $1.91 | $171.71 $114.47 (33%) | 🛒 Add to cart |
| 90 | $1.76 | $257.56 $158.65 (38%) | 🛒 Add to cart |
| 120 | $1.67 | $343.41 $199.82 (42%) | 🛒 Add to cart |
| 180 | $1.57 | $515.12 $282.16 (45%) | 🛒 Add to cart |
| 270 | $1.51 | $772.67 $408.68 (47%) | 🛒 Add to cart |
| 360 | $1.47
Best per pill | $1030.23 $528.17 (49%) | 🛒 Add to cart |
Duratia (Dapoxetine Hydrochloride) is a selective serotonin reuptake inhibitor specifically indicated for the treatment of premature ejaculation (PE) in adult men. Developed to address a significant unmet need in sexual medicine, this short-acting pharmacological agent offers a targeted approach to ejaculatory control, allowing for improved sexual satisfaction and relationship dynamics. Its rapid onset and short half-life make it uniquely suited for on-demand use, distinguishing it from other SSRIs traditionally used off-label for this condition. Clinical trials have demonstrated significant improvements in intravaginal ejaculatory latency time (IELT) and patient-reported outcomes related to control over ejaculation and distress.
Features
- Active ingredient: Dapoxetine Hydrochloride 30mg or 60mg
- Pharmacological class: Selective serotonin reuptake inhibitor (SSRI)
- Rapid onset of action: Approximately 1-2 hours
- Short elimination half-life: ~1.5 hours
- Film-coated tablet formulation for easy swallowing
- Available in blister packs of 1, 3, or 6 tablets
- Temperature-stable formulation requiring no refrigeration
- Pre-measured dosing eliminates need for titration in most cases
Benefits
- Significantly increases intravaginal ejaculatory latency time (IELT) by 3-4 fold compared to placebo
- Provides predictable and reliable control over ejaculation when taken as needed
- Rapid clearance minimizes residual drug effects between doses
- Improves patient-reported outcomes including perceived control and sexual satisfaction
- Reduces personal distress and interpersonal difficulty related to premature ejaculation
- On-demand dosing regimen aligns naturally with sexual activity patterns
Common use
Duratia is specifically indicated for the treatment of premature ejaculation in adult men aged 18-64 years. The medication is designed for on-demand use approximately 1-3 hours before anticipated sexual activity. Clinical studies have demonstrated efficacy in both lifelong and acquired premature ejaculation subtypes. The medication is intended for men in stable sexual relationships and should be used in conjunction with psychological interventions when appropriate. Treatment response is typically assessed after 4-6 uses, though many patients report noticeable improvement from the first dose.
Dosage and direction
The recommended starting dose is 30mg taken orally with a full glass of water approximately 1-3 hours before anticipated sexual activity. The tablet should be swallowed whole and not crushed or chewed. Based on efficacy and tolerability, the dose may be increased to 60mg. The maximum recommended dosing frequency is once every 24 hours. Patients should avoid excessive alcohol consumption (more than 5 units) when taking Duratia, as this may increase the risk of adverse events including syncope. The medication may be taken with or without food, though high-fat meals may delay absorption by approximately 30 minutes.
Precautions
Patients should be carefully evaluated for underlying medical conditions that might predispose them to adverse events. Orthostatic hypotension has been reported; patients should be cautioned about standing up quickly from a sitting or lying position. Use with caution in patients with history of syncope or pre-syncopal symptoms. Monitor for signs of serotonin syndrome, particularly when used concomitantly with other serotonergic drugs. Patients should be advised to avoid activities requiring complete alertness until they know how Duratia affects them. Regular assessment of treatment benefit and side effects is recommended, with consideration given to periodic treatment discontinuation to assess ongoing need.
Contraindications
Duratia is contraindicated in patients with known hypersensitivity to dapoxetine or any excipients in the formulation. Concurrent administration with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy is contraindicated due to risk of serotonin syndrome. The medication is contraindicated in patients with significant hepatic impairment (Child-Pugh class C). Patients with history of mania or severe depression should not use Duratia. Contraindicated in patients with clinically significant heart disease including heart failure, conduction abnormalities, and unstable angina. Concurrent use with thioridazine is contraindicated.
Possible side effects
The most commonly reported adverse reactions (≥5%) include nausea (11.0%), dizziness (5.8%), headache (5.6%), and diarrhea (3.9%). Less frequent side effects include insomnia (2.1%), fatigue (1.9%), anxiety (1.8%), and blurred vision (1.5%). Syncope or loss of consciousness occurred in approximately 0.06% of patients in clinical trials. Orthostatic hypotension was reported in 2.6% of patients. Most adverse events are mild to moderate in severity and tend to decrease in frequency with continued use. Serious but rare adverse events include serotonin syndrome and prolonged erection.
Drug interaction
Dapoxetine is primarily metabolized by multiple CYP enzymes including CYP3A4, CYP2D6, and CYP2C19. Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) increase dapoxetine exposure approximately 3-fold and concurrent use is not recommended. Moderate CYP3A4 inhibitors should be used with caution. Concurrent use with other SSRIs, SNRIs, tricyclic antidepressants, or tramadol may increase risk of serotonin syndrome. Potent CYP2D6 inhibitors may increase dapoxetine exposure by approximately 50%. The medication may potentiate the effects of alcohol and other CNS depressants. Use with alpha-adrenergic blockers may increase risk of orthostatic hypotension.
Missed dose
As Duratia is taken on an as-needed basis rather than on a scheduled regimen, the concept of a “missed dose” does not apply in the conventional sense. If a patient forgets to take Duratia before sexual activity, they should not take a double dose. The medication should be taken only when needed for sexual activity, with at least 24 hours between doses. Patients should be educated that the medication is intended for intermittent use rather than continuous dosing, and that taking it more frequently than recommended will not improve efficacy but may increase side effects.
Overdose
In case of overdose, supportive measures should be instituted based on clinical presentation. Expected symptoms may include serotonin syndrome manifestations (agitation, confusion, tachycardia, hyperthermia), dizziness, nausea, vomiting, and syncope. There is no specific antidote for dapoxetine overdose. Gastric lavage may be considered if presented within one hour of ingestion. Activated charcoal may be administered. Monitoring of vital signs and ECG is recommended, particularly watching for QT prolongation. Symptomatic treatment for serotonin syndrome may include benzodiazepines, cooling measures, and in severe cases, cyproheptadine. Dialysis is unlikely to be effective due to high protein binding.
Storage
Store at room temperature between 15-30°C (59-86°F). Protect from moisture and light. Keep in the original blister packaging until time of use. Do not store in bathroom cabinets where humidity levels may fluctuate. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly dispose of any unused medication that has expired or is no longer needed through medication take-back programs or according to local regulations.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Duratia is a prescription medication that should be used only under the supervision of a qualified healthcare provider. Individual results may vary. Patients should consult with their healthcare provider for proper diagnosis and treatment recommendations. The full prescribing information should be reviewed before initiating therapy. This medication is not intended for use in women or children.
Reviews
Clinical studies involving over 6,000 patients demonstrated that Duratia significantly improved all primary and secondary endpoints compared to placebo. In phase III trials, mean IELT increased from 0.9 minutes at baseline to 3.8 minutes at endpoint in the 60mg group. Patient Global Impression of Change questionnaires showed 85% of patients reported “much improved” or “very much improved” versus 25% for placebo. Treatment satisfaction scales indicated significant improvement in sexual relationship satisfaction. Real-world evidence studies have confirmed the maintenance of efficacy over 12 months of treatment with consistent safety profile. The medication has received positive evaluations in quality of life assessments specifically related to sexual function.